SG Americas Securities’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.7M Sell
23,113
-3,847
-14% -$1.92M 0.02% 682
2025
Q4
$13.1M Buy
26,960
+12,663
+89% +$5.9M 0.02% 646
2025
Q3
$5.99M Buy
14,297
+7,483
+110% +$2.52M 0.02% 449
2025
Q2
$1.96M Sell
6,814
-3,271
-32% -$978K 0.01% 777
2025
Q1
$3.11M Buy
10,085
+6,841
+211% +$2.34M 0.01% 630
2024
Q4
$1.15M Buy
3,244
+1,751
+117% +$644K 0.01% 803
2024
Q3
$535K Buy
1,493
+594
+66% +$201K ﹤0.01% 1631
2024
Q2
$286K Sell
899
-13,416
-94% -$3.55M ﹤0.01% 1990
2024
Q1
$3.29M Buy
14,315
+9,133
+176% +$2.06M 0.02% 692
2023
Q4
$1.14M Sell
5,182
-8,516
-62% -$1.96M 0.01% 955
2023
Q3
$3.09M Buy
+13,698
New +$3.16M 0.04% 497
2023
Q2
Sell
-5,914
Closed -$1.32M 3204
2023
Q1
$1.32M Sell
5,914
-8,826
-60% -$2.18M 0.02% 946
2022
Q4
$4.1M Buy
+14,740
New +$3.72M 0.06% 307
2022
Q3
Sell
-9,030
Closed -$2.13M 3585
2022
Q2
$2.13M Buy
9,030
+4,822
+115% +$980K 0.03% 715
2022
Q1
$755K Sell
4,208
-6,833
-62% -$1.3M 0.01% 1620
2021
Q4
$2.39M Buy
11,041
+2,681
+32% +$526K 0.02% 948
2021
Q3
$1.54M Buy
8,360
+3,340
+67% +$658K 0.01% 1517
2021
Q2
$901K Sell
5,020
-4,470
-47% -$851K ﹤0.01% 1624
2021
Q1
$1.59M Buy
9,490
+1,576
+20% +$263K 0.01% 1202
2020
Q4
$1.2M Sell
7,914
-13,261
-63% -$1.74M 0.01% 1439
2020
Q3
$2.14M Buy
21,175
+9,613
+83% +$1.05M 0.02% 700
2020
Q2
$1.4M Buy
11,562
+4,763
+70% +$536K 0.02% 1091
2020
Q1
$645K Sell
6,799
-6,310
-48% -$600K 0.01% 1624
2019
Q4
$1.16M Sell
13,109
-4,835
-27% -$425K 0.01% 1170
2019
Q3
$1.43M Sell
17,944
-1,500
-8% -$121K 0.01% 1184
2019
Q2
$1.52M Buy
19,444
+10,153
+109% +$949K 0.01% 1177
2019
Q1
$1.09M Sell
9,291
-106
-1% -$12.4K 0.01% 1229
2018
Q4
$1.02M Sell
9,397
-3,264
-26% -$378K 0.01% 1308
2018
Q3
$1.62M Buy
12,661
+3,093
+32% +$383K 0.01% 1326
2018
Q2
$1.08M Buy
9,568
+1,450
+18% +$159K 0.01% 1366
2018
Q1
$912K Sell
8,118
-1,958
-19% -$249K 0.01% 1422
2017
Q4
$1.49M Sell
10,076
-723
-7% -$91.9K 0.02% 1080
2017
Q3
$1.27M Buy
10,799
+436
+4% +$55.7K 0.01% 1090
2017
Q2
$1.34M Sell
10,363
-1,195
-10% -$149K 0.01% 1177
2017
Q1
$1.56M Sell
11,558
-13,014
-53% -$1.97M 0.01% 1061
2016
Q4
$3.52M Buy
24,572
+17,268
+236% +$2.2M 0.03% 629
2016
Q3
$862K Sell
7,304
-5,993
-45% -$720K 0.01% 1291
2016
Q2
$1.41M Sell
13,297
-6,047
-31% -$675K 0.01% 1074
2016
Q1
$2.16M Buy
19,344
+6,693
+53% +$847K 0.02% 814
2015
Q4
$1.98M Buy
12,651
+3,818
+43% +$556K 0.02% 713
2015
Q3
$1.16M Sell
8,833
-4,340
-33% -$696K 0.01% 793
2015
Q2
$2.29M Buy
13,173
+6,871
+109% +$1.24M 0.02% 657
2015
Q1
$1.09M Sell
6,302
-485
-7% -$73.9K 0.01% 1109
2014
Q4
$879K Sell
6,787
-1,612
-19% -$208K ﹤0.01% 1299
2014
Q3
$1.08M Sell
8,399
-14,316
-63% -$1.48M 0.01% 1129
2014
Q2
$2.01M Buy
22,715
+17,730
+356% +$1.71M 0.01% 992
2014
Q1
$469K Sell
4,985
-2,102
-30% -$215K ﹤0.01% 1507
2013
Q4
$801K Sell
7,087
-12,462
-64% -$1.12M ﹤0.01% 1309
2013
Q3
$1.54M Buy
19,549
+15,603
+395% +$1.14M 0.01% 1070
2013
Q2
$260K Buy
+3,946
New +$254K ﹤0.01% 1587

Other funds holding UTHR